Industry-funded medical research will double your impact factor
The Guardian has a nice piece by Ben Goldarcre reporting about a study published by the British Medial Journal entitled “Relation of study quality, concordance, take home message, funding, and impact in studies of influenza vaccines: systematic review”. Both the newpaper article and the study are worth reading and seem to be open. Besides many other interesting findings, the BMJ article finds that the journal impact factor of industry-funded studies of influenza vaccines (both Ben and I find it quite likely that this is not limited to the study of influenza vaccines :-)) are on average more than twice as high as those for purely academic studies (Impact Factor 3.74 vs 8.78). Judge yourself.